Product Details

Veramox Capsules meet British Pharmacopoeia (BP) standards for the treatment of bacterial infections. Specifically, each capsule delivers Amoxycillin Trihydrate equivalent to 250mg Amoxycillin. As a result, it offers broad-spectrum antibacterial coverage for common infections in outpatient and hospital settings.

The capsules contain:

• Amoxycillin Trihydrate IP (equivalent to Amoxycillin 250mg) – A broad-spectrum, beta-lactam antibiotic of the aminopenicillin class that inhibits bacterial cell wall synthesis. Consequently, it disrupts the structural integrity of susceptible bacteria, leading to cell lysis and death.

Physicians prescribe Veramox for the treatment of susceptible bacterial infections, including respiratory tract infections, ear, nose, and throat infections, urinary tract infections, and skin and soft tissue infections. In addition, its oral capsule format supports convenient outpatient dosing across a wide range of clinical settings. Because of this profile, Veramox suits general practice, paediatric, and hospital settings where reliable antibacterial therapy is needed.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the oral capsule format supports easy, convenient dosing
• Furthermore, each capsule delivers precise, validated dosage accuracy at 250mg
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, blister packaging protects capsule integrity against light and moisture
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies